Birdwatch Archive

Birdwatch Note Rating

2024-03-19 19:20:51 UTC - HELPFUL

Rated by Participant: 1B312FF9E5FF50AC05B78AAD7EC17361308922F4752B8A0990D071C8D2E926A4
Participant Details

Original Note:

The FDA has issued warnings about unapproved formulations of Semaglutide (Better known as Oxempic) for weight loss. Wegovy is the only Semaglutide formulation approved by the FDA for weight loss. This drug may have the same ‘active ingredient’ but it is not the same drug. https://www.cnn.com/2023/05/30/health/fda-compounding-semaglutide/index.html

All Note Details

Original Tweet

All Information

  • noteId - 1768763409279963319
  • participantId -
  • raterParticipantId - 1B312FF9E5FF50AC05B78AAD7EC17361308922F4752B8A0990D071C8D2E926A4
  • createdAtMillis - 1710876051375
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 17687634092799633191B312FF9E5FF50AC05B78AAD7EC17361308922F4752B8A0990D071C8D2E926A4